More Globe Newswire

View Older Stories View Newer Stories

Jan 8, 2026 07:00AM Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies
Jan 8, 2026 07:00AM GlycoEra Appoints Petra Duda, M.D., Ph.D., as Chief Medical Officer to Advance Precision Immune Degrader Pipeline
Jan 8, 2026 07:00AM Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
Jan 8, 2026 07:00AM Tisento Therapeutics Completes Enrollment in PRIZM, a Global Phase 2b Study of Zagociguat for the Treatment of MELAS
Jan 8, 2026 07:00AM Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
Jan 8, 2026 07:00AM Lantronix to Attend 28th Annual Needham Growth Conference on Jan. 13, 2026
Jan 8, 2026 07:00AM Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Jan 8, 2026 07:00AM AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
Jan 8, 2026 07:00AM Aurora Mobile Congratulates Zhipu on Successful Hong Kong Listing
Jan 8, 2026 07:00AM Brunswick Exploration Announces Inferred Mineral Resource of 52.2Mt at 1.08% Li2O at Mirage with Additional Exploration Target
Jan 8, 2026 07:00AM Surge Copper Advances Berg Toward Pre-Feasibility with Successful 2025 Drilling and Data Validation Program
Jan 8, 2026 07:00AM Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
Jan 8, 2026 07:00AM Woof Gang Achieves Record Growth in 2025
Jan 8, 2026 07:00AM Anika Therapeutics Announces Leadership Transition
Jan 8, 2026 07:00AM ONAR Completes Sale of Certain Legacy Assets in a Secured $1.5 Million Seller-Financed Transaction
Jan 8, 2026 07:00AM Transpire Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
Jan 8, 2026 07:00AM Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
Jan 8, 2026 07:00AM Cullinan Therapeutics Provides Corporate Update and Highlights Anticipated 2026 Milestones
Jan 8, 2026 07:00AM Troilus Delivers on Key Development Milestones in 2025 and Enters a Pivotal Transition Year in 2026
Jan 8, 2026 07:00AM Kinross to provide update on Round Mountain Phase X, Kettle River-Curlew and Bald Mountain Redbird 2 projects
Jan 8, 2026 07:00AM Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases
Jan 8, 2026 07:00AM AAVantgarde to Present at the 44th Annual J.P. Morgan Healthcare Conference
Jan 8, 2026 07:00AM Sagimet Biosciences Announces Poster Presentation at the 10th Annual MASH-TAG 2026 Conference
Jan 8, 2026 07:00AM Fixing of coupon rates – Nykredit Realkredit A/S
Jan 8, 2026 07:00AM Net Asset Value(s)
Jan 8, 2026 07:00AM Enara Bio Enters 2026 with Dark Antigen Licensing to Boehringer Ingelheim, Appointment of Chief Medical Officer and Plans to Advance DARKFOX T-cell Engager into First-in-Human Studies
Jan 8, 2026 07:00AM AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
Jan 8, 2026 07:00AM Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study
Jan 8, 2026 07:00AM CMR Surgical receives CE Mark for use of Versius in paediatric surgery
Jan 8, 2026 07:00AM BitMEX Report Finds Crypto Perpetuals Enter Post-Yield Era
Jan 8, 2026 07:00AM Indivior Provides Full-Year 2026 Financial Guidance and Business Update
Jan 8, 2026 06:59AM Fury Reviews 2025 Achievements and Outlines 2026 Exploration Priorities
Jan 8, 2026 06:57AM Lleida.net Begins 2026 With a 55.62% Increase in Clients Driven by Regulatory Demand
Jan 8, 2026 06:50AM Endeavour Silver Produces 6,486,661 Oz Silver and 37,164 Oz Gold, for a total of 11.2 Million Silver Equivalent Oz in 2025
Jan 8, 2026 06:50AM RentRedi Recognized for Premier Customer Service by National Association of Realtors®
Jan 8, 2026 06:45AM Bridge Specialty Group acquires the assets of Shoemaker & Besser Associates, Inc.
Jan 8, 2026 06:45AM Brookfield Asset Management to Host Fourth Quarter and Full Year 2025 Results Conference Call
Jan 8, 2026 06:45AM Bridge Specialty Group acquires the assets of Shoemaker & Besser Associates, Inc.
Jan 8, 2026 06:45AM Summit Royalties Provides Corporate Update and Highlights 2026 Catalysts
Jan 8, 2026 06:38AM Jiangxi Fengcheng Hosts Circular Economy Industry Innovation and Development Conference, Sharing Experience in Green Transformation of China's Counties
Jan 8, 2026 06:38AM Jiangxi Fengcheng Hosts Circular Economy Industry Innovation and Development Conference, Sharing Experience in Green Transformation of China's Counties
Jan 8, 2026 06:30AM Defiance’s XMAG ETF, the First ETF Offering Exposure to the S&P 500 Excluding the “Magnificent Seven,” Surpasses $100 Million in AUM
Jan 8, 2026 06:30AM Teleflex Announces Leadership Transition
Jan 8, 2026 06:30AM Defiance’s XMAG ETF, the First ETF Offering Exposure to the S&P 500 Excluding the “Magnificent Seven,” Surpasses $100 Million in AUM
Jan 8, 2026 06:30AM Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline
Jan 8, 2026 06:30AM NervGen Pharma Begins Trading on Nasdaq Today
Jan 8, 2026 06:29AM FERRARI TO ANNOUNCE 2025 FULL YEAR AND FOURTH QUARTER FINANCIAL RESULTS ON FEBRUARY 10
Jan 8, 2026 06:00AM Rogers Launches Five-Year $50 Million National Program to Help Youth Balance Screen Time
Jan 8, 2026 06:00AM Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
Jan 8, 2026 06:00AM Radware Unveils “ZombieAgent”: A Newly Discovered Zero-Click, AI Agent Vulnerability Enabling Silent Takeover and Cloud-Based Data Exfiltration
View Newer Stories View Older Stories